London, United Kingdom
Houston, United States
Hong Kong, China
San Diego, California
Maple Grove, Minnesota
New Delhi, India
Sao Paulo, Brazil
Nagatacho - Tokyo, Japan
Heiwajima - Tokyo, Japan
Maidenhead, United Kingdom
Gloucester, United Kingdom
Paris (Chatillon), France
Recently, surgeons from the Netherlands, Italy and Switzerland experienced successful procedures with Perceval Plus, which is well-positioned in European markets to become an essential component to any comprehensive heart program.
read the story
LivaNova recently hosted U.S. Rep. Markwayne Mullin (R-OK) for a site visit at our Houston facility. During the visit, Rep. Mullin learned about the diversity of LivaNova business franchises and products, and also toured the facility’s manufacturing operations.
Dr. Michael Ettner suffered from depression for years until he was implanted with our VNS Therapy for depression device. Recently, he visited our Houston facility to share his impactful personal story, his journey to overcome depression and how VNS Therapy has helped him in this battle.
Recently, five Houston employees were presented with challenge coins for their work or passion in exemplifying one of our Four Pillars. This new recognition program is based off the LivaNova4YOU survey.
LivaNova announced the U.S. Centers for Medicare & Medicaid Services (CMS) accepted our protocol for our RECOVER trial. This is a major milestone for our Depression therapeutic business area.
he LivaNova International Fellowship (LIFE) was established as a corporate social responsibility program by our company to give back to society. The program’s initiatives helped more than 180 patients in 11 countries around the world in the past eight months and it is continuing to grow.
Managing Our Travel Expenses
read the message
Supporting organizations that care for the head and the heart is a cornerstone of our culture at LivaNova. Recently, 29 employees at our Vancouver location continued that tradition by hopping on a “Big Bike” to support the Heart & Stroke Foundation of Canada.
“Get to Know” is our monthly series that focuses on a specific area of LivaNova to give you a better understanding of how it contributes to the success of our company. This month, we take a closer look at our facility in Arvada.
A collaboration agreement between Johns Hopkins Technology Ventures and LivaNova has been announced to evaluate, access and invest in Johns Hopkins-based technologies.
LivaNova employees in the UK recently teamed up to cycle 1,006 miles and raise more than £1,000 for the UK Epilepsy Society by participating in the LivaNova UK Ltd Cycle Challenge.
Forty years ago, doctors replaced Nicole Sarim's aortic valve with one of our mechanical aortic heart valves. Recently, she visited Saluggia to learn more about our company and discuss her experience with our product.
LivaNova Houston employees visited Camp Spike ‘n’ Wave, where they met with children and teens living with epilepsy, and heard the impactful story of a VNS Therapy® patient.
LivaNova Announces Second Quarter 2019 Financial Results
Workday empowers employees and managers to efficiently manage, track and report talent processes. Now, Workday Recruit brings the second phase of this global tool to LivaNova.
The LivaNova Women’s Network recently recognized its first class of graduates. This mentorship program was established as a pilot program in Houston to build future leaders in our company.
As a large global company, we have many different stakeholders, functions and departments. In the first edition of our new “Get to Know” monthly series, we take a look at Global Procurement.
The new product is now the only bidirectional arterial cannula designed to prevent leg ischemia during cardiac surgery procedures requiring femoral artery cannulation.
LivaNova announced a new chapter in Advanced Circulatory Support innovation today as our LifeSPARC system received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
LivaNova reached a significant milestone in our company history with our Vagus Nerve Stimulation Therapy® (VNS Therapy) System.
LivaNova recently hosted U.S. Rep. Mike Kelly (R-PA) for a site visit at our TandemLife facility in Pittsburgh.
Our company was highly-ranked in a recent list of companies that profoundly impact the cardiovascular market.
LivaNova Announces Closing of Asset Purchase from Miami Instruments
Our Munich facility recently participated in Girls Day and hosted four young adults at the facility to motivate and encourage girls to consider a technical career.
Paul Buckman named President, North America
More than 900 employees participated when the Employee Stock Purchase Plan was opened at the end of 2018. Another enrollment period is taking place from June 3 through June 14.
The LIFE initiative is continuing its mission of developing and delivering health innovation where there is an unmet community need.
The first Perceval patient in Japan was recently implanted with the product at the prestigious Osaka University Hospital.
Leadership Appointments for our TRD Business
Attracting, retaining and developing top talent is a crucial pillar to the success of LivaNova. To that end, employees from our Munich facility recently sought to add talent by taking part in a local recruiting event.
Resetting Our Expense Structure
LivaNova Announces First Quarter 2019 Financial Results
Shaping the Future of TRD
Recently, the LivaNova Heart Failure team presented long-term follow-up results from the ANTHEM-HF pilot study.
Watch a highlight video from an employee town hall held in March 2019.
Watch the video
The visit included meeting with the Executive Leadership Team and employees, touring the Neuromodulation manufacturing areas and conducting interviews with local media.
More than 500 employees entered the contest. Ten winners who answered all the questions correctly were chosen at random to receive a prize.
A new $3-million trigeneration plant built on site at our Mirandola, Italy facility is helping us take big steps in the quest to lower our carbon footprint.
A Message from Marco Dolci
LivaNova Reports Preliminary Unaudited First Quarter 2019 Revenue Results
Read the story
Hundreds of LivaNova employees adventurously took to the streets of Kuala Lumpur, competing in a treasure hunt to benefit epilepsy patients.
READ THE STORY
Collaboration is happening across all parts of the company. The efforts taking place to share information and learn from colleagues is a prime example of successful teamwork in action.
watch the video
Welcome to the EDGE - our Employee Dedicated Global Exchange. Our new intranet experience is for all LivaNova employees.
Trui Hebbelinck appointed Chief Human Resources Officer
LivaNova Announces 4Q & FY 2018 Financial Results
Final Decision from CMS Regarding VNS Therapy for Depression
North America Organizational Announcement